A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Market Analysis and Insights: Global and United States Neuronal Markers Market
This report focuses on global and United States Neuronal Markers market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Neuronal Markers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Imaging Biomarkers accounting for % of the Neuronal Markers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Spinal Muscular Atrophy (SMA) was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Neuronal Markers market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Neuronal Markers Scope and Market Size
Neuronal Markers market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Neuronal Markers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Neuronal Markers market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Neuronal Markers market is segmented into
Imaging Biomarkers
Metabolomics Biomarkers
Proteomic Biomarkers
Genomics Biomarkers
Segment by Application, the Neuronal Markers market is segmented into
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Depression
Schizophrenia
Huntington's Disease
Parkinson's Disease
Alzheimer's Disease
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Neuronal Markers Market Share Analysis
Neuronal Markers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuronal Markers business, the date to enter into the Neuronal Markers market, Neuronal Markers product introduction, recent developments, etc.
The major vendors covered:
Athena Diagnostics
Myriad RBM
AbaStar MDx
QIAGEN
Thermo Fisher Scientific
Table of Contents
1 Study Coverage
1.1 Neuronal Markers Product Introduction
1.2 Global Neuronal Markers Outlook 2017 VS 2022 VS 2028
1.2.1 Global Neuronal Markers Sales in US$ Million for the Year 2017-2028
1.2.2 Global Neuronal Markers Sales in Volume for the Year 2017-2028
1.3 United States Neuronal Markers Outlook 2017 VS 2022 VS 2028
1.3.1 United States Neuronal Markers Sales in US$ Million for the Year 2017-2028
1.3.2 United States Neuronal Markers Sales in Volume for the Year 2017-2028
1.4 Neuronal Markers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Neuronal Markers in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Neuronal Markers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Neuronal Markers Market Dynamics
1.5.1 Neuronal Markers Industry Trends
1.5.2 Neuronal Markers Market Drivers
1.5.3 Neuronal Markers Market Challenges
1.5.4 Neuronal Markers Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Neuronal Markers Market Segment by Type
2.1.1 Imaging Biomarkers
2.1.2 Metabolomics Biomarkers
2.1.3 Proteomic Biomarkers
2.1.4 Genomics Biomarkers
2.2 Global Neuronal Markers Market Size by Type
2.2.1 Global Neuronal Markers Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Neuronal Markers Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Neuronal Markers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Neuronal Markers Market Size by Type
2.3.1 United States Neuronal Markers Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Neuronal Markers Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Neuronal Markers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Neuronal Markers Market Segment by Application
3.1.1 Spinal Muscular Atrophy (SMA)
3.1.2 Multiple Sclerosis
3.1.3 Depression
3.1.4 Schizophrenia
3.1.5 Huntington's Disease
3.1.6 Parkinson's Disease
3.1.7 Alzheimer's Disease
3.2 Global Neuronal Markers Market Size by Application
3.2.1 Global Neuronal Markers Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Neuronal Markers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Neuronal Markers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Neuronal Markers Market Size by Application
3.3.1 United States Neuronal Markers Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Neuronal Markers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Neuronal Markers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Neuronal Markers Competitor Landscape by Company
4.1 Global Neuronal Markers Market Size by Company
4.1.1 Top Global Neuronal Markers Manufacturers Ranked by Revenue (2021)
4.1.2 Global Neuronal Markers Revenue by Manufacturer (2017-2022)
4.1.3 Global Neuronal Markers Sales by Manufacturer (2017-2022)
4.1.4 Global Neuronal Markers Price by Manufacturer (2017-2022)
4.2 Global Neuronal Markers Concentration Ratio (CR)
4.2.1 Neuronal Markers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Neuronal Markers in 2021
4.2.3 Global Neuronal Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Neuronal Markers Manufacturing Base Distribution, Product Type
4.3.1 Global Neuronal Markers Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Neuronal Markers Product Type
4.3.3 Date of International Manufacturers Enter into Neuronal Markers Market
Summary: Get latest Market Research Reports on Neuronal Markers. Industry analysis & Market Report on Neuronal Markers is a syndicated market report, published as Global and United States Neuronal Markers Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Neuronal Markers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.